ORTHOCELL LIMITED

0.44%

$1.14

Market Cap $277.8M

Technology Scientific & Technical Instruments

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Latest Threads

Tag

Subject

OCC

OCC Trading

40 41 42

04/09/25

2.5K

905K

04/09/25

Last post kdwc

2.5K

905K

OCC

Ann: Appendix 4E & Annual Report

03/09/25

3.7K

03/09/25

Last post rae915

3.7K

OCC

Ann: Cleansing Notice

03/09/25

199

03/09/25

Last post

ASX News

199

OCC

Ann: Application for quotation of securities - OCC

03/09/25

355

03/09/25

Last post MixedBag

355

OCC

Ann: Replacement Initial Director's Interest Notice

01/09/25

576

01/09/25

Last post jcurve

576

OCC

Ann: Notification regarding unquoted securities - OCC

01/09/25

162

01/09/25

Last post

ASX News

162

OCC

Ann: Initial Director's Interest Notice - Mr Michael McNulty

01/09/25

205

01/09/25

Last post

ASX News

205

OCC

Media thread

18 19 20

01/09/25

1.1K

455K

01/09/25

Last post MikesLM

1.1K

455K

See All Discussions

Timeline

Cleansing Notice
03 Sep 16:35	Share

Application for quotation of securities - OCC
03 Sep 16:32	Share

Replacement Initial Director's Interest Notice
01 Sep 16:56	Share

Notification regarding unquoted securities - OCC
01 Sep 16:48	Share

Initial Director's Interest Notice - Mr Michael McNulty
01 Sep 16:38	Share

Appendix 4G
29 Aug 12:31	Share

Corporate Governance Statement
29 Aug 12:30	Share

Appendix 4E & Annual Report
29 Aug 12:28	Share

Investor Presentation Canaccord Annual Growth Conference
15 Aug 09:22	Share

Remplir Commericalisation into $1.6B US Market Gathers Pace
13 Aug 08:48	Share

Notification regarding unquoted securities - OCC
28 Jul 18:11	Share

Option Terms and Conditions
28 Jul 17:14	Share

Proposed issue of securities - OCC
28 Jul 17:12	Share

Final Director's Interest Notice
25 Jul 09:31	Share

Proposed issue of securities - OCC
25 Jul 09:30	Share

Orthocell Announces Changes to Board of Directors
25 Jul 09:04	Share

Notification of cessation of securities - OCC
14 Jul 08:29	Share

Cleansing Notice
10 Jul 16:20	Share

Application for quotation of securities - OCC
10 Jul 16:18	Share

Orthocell Announces First US Remplir Sales Revenue
10 Jul 09:03	Share

Quarterly Activity Report & Appendix 4C
09 Jul 09:00	Share

Remplir US Rollout & 1st Surgery Investor Update
02 Jul 12:46	Share

Orthocell Bolsters Leadership with Key Hires
02 Jul 09:03	Share

Record Revenue of $2.73m in June 25 Quarter up 22.8% QoQ
01 Jul 09:03	Share

Investor Webinar
27 Jun 09:50	Share

First Surgical Use of Remplir in US$1.6 Billion US Market
27 Jun 09:01	Share

Compelling Data Highlights Remplir Competitive Advantage
19 Jun 08:59	Share

Cleansing Notice
10 Jun 16:48	Share

Application for quotation of securities - OCC
10 Jun 16:45	Share

Remplir Approved to Commence Sales in the Hong Kong Market
12 May 08:56	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.14		Change 0.005(0.44%)		Mkt cap ! $277.8M

Open	High	Low	Value	Volume
$1.15	$1.17	$1.13	$550.0K	476.1K

Buyers (Bids)

No.	Vol.	Price($)
1	815	$1.14

Sellers (Offers)

Price($)	Vol.	No.
$1.17	138651	6

View Market Depth

No.	Vol.	Price($)
1	815	1.135
6	16753	1.130
3	14892	1.120
4	15200	1.110
2	57000	1.105

Price($)	Vol.	No.
1.170	138651	6
1.190	17500	1
1.195	18000	3
1.200	42752	3
1.205	43135	1

Last trade - 16.10pm 04/09/2025 (20 minute delay)

OCC (ASX) Chart

ORTHOCELL LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come

04 Dec 2024 15:54 (AEDT)

Latest Articles

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Orthocell (ASX:OCC) shares notched upwards on Friday as the company announced its nerve repair product has been...

Orthocell sees US Remplir sales on immediate horizon as distro deal locked in

Orthocell (ASX:OCC) has locked in a U.S. distributor deal for its flagship product and biotech punter favourite Remplir, leaving the company confident U.S. sales are about to kick off. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from througho...

Orthocell spikes 7% after clearing huge US hurdle for its nerve repair product

The stock’s bull run over the last two months has seen its share price more than double as investors eye the lucrative $1.6B nerve repair market in the US.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News